carbonthatcarbonthat
← Every fund

Biotechnology Ultrasector Profund

Filed by ProFunds. What this fund reported holding in its latest quarterly NPORT-P. Positions are ordered by share of the fund rather than by size, because that is what separates a conviction from a rounding error.

Positions
42
matched to a ticker
Fund size
$220.5M
the filing's own figure
Matched value
$37.1M
of the positions below
As of
2026-07-31
S000003107

What it holds

Largest share of the fund first.

Company% of fundValue
TWSTTwist Bioscience Corp1.08%$1.3M
PRAXPraxis Precision Medicines Inc1.02%$1.2M
REGNRegeneron Pharmaceuticals Inc1.01%$1.2M
COGTCogent Biosciences Inc0.99%$1.2M
NTRANatera Inc0.99%$1.2M
ARWRArrowhead Pharmaceuticals Inc0.95%$1.1M
RLAYRelay Therapeutics Inc0.95%$1.1M
MRNAModerna Inc0.95%$1.1M
PCVXVaxcyte Inc0.95%$1.1M
BBIOBridgeBio Pharma Inc0.95%$1.1M
HALOHalozyme Therapeutics Inc0.93%$1.1M
CYTKCytokinetics Inc0.92%$1.1M
AMGNAmgen Inc0.91%$1.1M
INCYIncyte Corp0.90%$1.1M
ABBVAbbVie Inc0.89%$1.1M
VRTXVertex Pharmaceuticals Inc0.87%$1M
KRYSKrystal Biotech Inc0.87%$1M
INSMInsmed Inc0.86%$1M
GILDGilead Sciences, Inc0.86%$1M
BMRNBioMarin Pharmaceutical Inc0.85%$1M
BIIBBiogen Inc0.83%$989.4K
NBIXNeurocrine Biosciences Inc0.83%$981.8K
ACADACADIA Pharmaceuticals Inc0.82%$978.4K
EXELExelixis Inc0.80%$954.9K
MDGLMadrigal Pharmaceuticals Inc0.79%$938.8K
UTHRUnited Therapeutics Corp0.76%$900.8K
RAREUltragenyx Pharmaceutical Inc0.73%$868.6K
IBRXImmunitybio Inc0.72%$852K
BCRXBioCryst Pharmaceuticals Inc0.69%$817K
ARQTArcutis Biotherapeutics Inc0.63%$744.2K
IONSIonis Pharmaceuticals Inc0.56%$668.6K
ALNYAlnylam Pharmaceuticals Inc0.56%$668.1K
VCYTVeracyte Inc0.56%$659.1K
SRPTSarepta Therapeutics Inc0.53%$630.3K
KODKodiak Sciences Inc0.50%$592.8K
NTLAIntellia Therapeutics Inc0.49%$584.6K
AGIOAgios Pharmaceuticals Inc0.48%$572.3K
NVAXNovavax Inc0.44%$523.7K
CDNACareDx Inc0.40%$476.5K
KURAKura Oncology Inc0.22%$264.3K
OCGNOcugen Inc0.14%$164K
EBSEmergent BioSolutions Inc0.10%$117.5K

Source: NPORT-P filings, via EDGAR. Positions arrive by CUSIP, and only a CUSIP verified against a ticker is kept — so this is what we could match, not everything the fund holds, and the matched value is therefore below the fund's own size. A balance is shares where the filing says `NS` and a principal amount where it says `PA`, which is why it is not labelled shares in both cases.

Follow Biotechnology Ultrasector Profund by email

Biotechnology Ultrasector Profund's new holdings reports, with the rest of the week's filings. One email a week, free.

Unsubscribe with one click from any email.

Related datasets

Whale MovesAnyone crossing five per cent, and whether they want a say.Institutional HoldingsWhich funds own these companies, and what they changed.SectorsEvery company by sector and industry, with valuations.Stock ScreensPiotroski, Graham, dividend records and most shorted.